Use of Mass Spectrometric Approaches to Tackle Challenges in Drug Discovery: The Beta-Amyloid Paradigm

Author:

Tsarbopoulos Anthony

Abstract

AbstractThe origin of many neurodegenerative disorders like Alzheimer’s Disease (AD) lies in protein processing failures, which leads to protein aggregation and accumulation as amyloid fibrils. Abnormal accumulation and aggregation of beta amyloid peptide (Aβ) eventually lead to the formation and cerebral deposition of amyloid plaques, the major pathological hallmark in AD. Aβ1-40 and Aβ1-42 are the predominant components of senile plaques formed in AD brain. The aggregation of Aβ is associated with neurodegeneration, loss of cognitive ability, and premature death. Understanding the aggregation mechanism and how to inhibit aggregate formation is therefore crucial. In light of the proposed link between oxidative stress, unregulated immune response and neurodegeneration, it is suggested that use of antioxidants may be beneficial for inhibiting Aβ fibrillogenesis. Therefore, endogenous and dietary antioxidants may offer a protective or even therapeutic alternative against amyloidosis. In this study, several compounds isolated from natural products are screened for the in vitro antiamyloidogenic activity. Novel electrospray ionization (ESI) mass spectrometry (MS)-based methodologies are employed to assess the noncovalent interactions between the Aβ and isolated components from natural products. The specificity and the stability of these noncovalent complexes were examined under different experimental conditions, whereas their relative binding strength was assessed. In addition, MS proteolytic mapping was employed to provide information on the noncovalent binding site of the bioactive molecule on the Aβ residues. This may shed some light into the mechanisms of AD pathology and provide insights into novel agents that can be employed towards prevention or even treatment of AD.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference39 articles.

1. E. von Strauss, M. Viitanen, D. De Ronchi, B. Winblad, and L. Fratiglioni, “Aging and the occurrence of dementia: Findings from a population-based cohort with a large sample of nonagenarians,” Arch Neurol 1999, 56, 587–592.

2. World Alzheimer’s Report 2013.

3. Karolinska Institute Report on Dementia 2010.

4. C. Behl, “Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches,” Prog. Neurobiol. 1999, 57, 301–323.

5. C.A. Ross and M.A. Poirier, “Protein aggregation and neurodegenerative disease,” Nat. Med. 2004, 10 (Suppl), S10–S17.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3